Overview: FiercePharma provides daily insider news from the post-approval world including manufacturing, labeling, post-marketing issues, and other pharmaceutical industry business topics.

Newsletter Subscribers: 32,000+

Publishing Schedule: daily

Audience: Senior pharmaceutical industry executives, project managers, and other business decision makers at pharmaceutical and related life sciences companies.

Reader Demographics

Company Type
Pharmaceutical - 33%
Biotechnology - 11%
Academia / Government Research / Other Research - 7%
Consulting - 18%
Marketing / Media - 5%
Finance / PE / VC - 5%
Other - 13%

Job Function
Corporate Management (CEO, CFO, COO, CIO, SVP, VP) - 26%
R&D and Lab Management - 23%
Sales & Marketing - 15%
Product/Brand Management - 6%
Licensing / Business Development - 4%
Finance - 5%
Manufacturing / Production - 3%
Regulatory / Labeling / Safety - 3%
IT - 1%
Other - 15%

Region
North America - 80%
Europe - 14%
Asia-Pacific - 4%
Central & South America - 1%

69% of FiercePharma readers have an advanced degree.

64% of FiercePharma readers supervise others.

64% of FiercePharma readers make purchasing decisions.

Top Companies Represented

Pfizer
Novartis
Lexgen
Johnson & Johnson
Sanofi-Aventis
GlaxoSmithKline
Bayer
Eli Lilly
Amgen
Wyeth
Bristol Myers Squibb
Roche
Genentech
Abbott Labs
Merck
AstraZeneca